COMMENTARY

MRSA: What Do We Tell Our Patients about Institutional Precautions in the Presence of Conflicting Universal Screening Data?

Paul G. Auwaerter, MD

Disclosures

April 16, 2008


This feature requires the newest version of Flash. You can download it here.
This feature requires the newest version of Flash. You can download it here.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....